Related Experiment Video

Updated: Apr 11, 2026

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
11:47

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer

Published on: February 8, 2013

12.6K

MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells

Resham Lal Gurung1, Shi Ni Lim, Grace Kah Mun Low

  • 1Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Journal of Nutrigenetics and Nutrigenomics
|May 30, 2015
PubMed
Abstract

Insights

MST-312, a tea catechin derivative, inhibits telomerase activity, causing telomere dysfunction and growth arrest in breast cancer cells. Combining MST-312 with poly(ADP-ribose) polymerase 1 (PARP-1) inhibition enhances these anti-cancer effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Telomerase targeting is a promising cancer therapy strategy due to unlimited cellular replication in cancers.
  • The DNA repair response to telomerase inhibition in breast cancer remains unclear.
  • Telomere dysfunction is recognized as double-strand breaks.

Purpose of the Study:

  • To investigate the effects of MST-312, a novel epigallocatechin gallate derivative, on telomere dynamics and DNA damage.
  • To analyze gene expression profiles related to DNA damage in breast cancer cells treated with MST-312.
  • To evaluate the potential of MST-312 as an anti-telomerase cancer therapy.

Main Methods:

  • Human breast cancer cell lines (MCF-7 and MDA-MB-231) were treated with MST-312.
  • Telomere-telomerase homeostasis, induced DNA damage, and gene expression were analyzed.
  • Cells were co-treated with MST-312 and a poly(ADP-ribose) polymerase 1 (PARP-1) inhibitor (PJ-34).

Main Results:

  • MST-312 reduced telomerase activity, induced telomere dysfunction, and caused growth arrest in breast cancer cells.
  • MDA-MB-231 cells showed more profound effects than MCF-7 cells, with downregulation of the telomere-protective protein TRF2.
  • MST-312 induced DNA damage at telomeres and reduced expression of ATM and RAD50 DNA damage genes.
  • Combined treatment with MST-312 and PJ-34 enhanced growth reduction compared to single treatments.

Conclusions:

  • MST-312 demonstrates potential as an anti-telomerase agent for breast cancer therapy.
  • Combination therapy with MST-312 and PARP-1 inhibition may offer enhanced therapeutic benefits.
  • Further research into MST-312 and PARP-1 inhibition is warranted for breast cancer treatment strategies.

More Related Videos

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells09:13

Generation of Cancer Cell Clones to Visualize Telomeric Repeat-containing RNA TERRA Expressed from a Single Telomere in Living Cells

Published on: January 17, 2019

7.9K
Processing of Human Reduction Mammoplasty and Mastectomy Tissues for Cell Culture13:08

Processing of Human Reduction Mammoplasty and Mastectomy Tissues for Cell Culture

Published on: January 3, 2013

17.1K

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Telomeres and Telomerase02:41

Telomeres and Telomerase

8.2K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
28.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K